teriflunomide mylan
mylan pharmaceuticals limited - teriflunomide - multippel sklerose, relapsing-remitting - immunsuppressive - teriflunomide mylan is indicated for the treatment of adult patients and paediatric patients aged 10 years and older (body weight > 40 kg) with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 of the smpc for important information on the population for which efficacy has been established).
teriflunomide accord
accord healthcare s.l.u. - teriflunomide - multippel sklerose, relapsing-remitting - immunosuppressants, selektiv immunosuppressants - teriflunomide accord is indicated for the treatment of adult patients and paediatric patients aged 10 years and older with relapsing remitting multiple sclerosis (ms) (please refer to section 5. 1 for important information on the population for which efficacy has been established).
produodopa 240 mg/ ml / 12 mg/ ml
abbvie as - foslevodopa / foskarbidopa - infusjonsvæske, oppløsning - 240 mg/ ml / 12 mg/ ml
oxycodone hameln 10 mg/ ml
hameln pharma gmbh - oksykodonhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 10 mg/ ml
oxycodone hameln 50 mg/ ml
hameln pharma gmbh - oksykodonhydroklorid - injeksjons-/infusjonsvæske, oppløsning - 50 mg/ ml
eprinex vet. 5 mg/ ml
boehringer ingelheim animal health nordics a/s - eprinomektin - påhellingsvæske, oppløsning - 5 mg/ ml
seroquel depot 400 mg
orifarm as - kvetiapinfumarat - depottablett - 400 mg
seroquel depot 400 mg
orifarm as - kvetiapinfumarat - depottablett - 400 mg
seroquel depot 400 mg
orifarm as - kvetiapinfumarat - depottablett - 400 mg
seroquel depot 150 mg
cheplapharm arzneimittel gmbh - kvetiapinfumarat - depottablett - 150 mg